Should have been done immediately when discovered months ago
This may point again to tissue fragility in people with clEDS
ET Saturday, June 6 DALLAS, JUNE 6, 2026 Among adults with both obesity and an autoimmune disease, those taking a glucagon-like peptide-receptor 1 agonist (GLP-1RA) medication had lower rates of emergency department visits and were less likely to experience serious cardiac events, such as stroke, pulmonary embolism or death when compared to similar adults who were not taking these medications, according to new research published today in the Journal of the American Heart Association , an open-access, peer-reviewed journal of the American Heart Association
10.1016/j.nbd.2012.02.007 Neurobiol
These are indicators of contamination or degradation that benzyl alcohol cannot reverse
Consultation: A licensed medical practitioner will assess your health history and determine if GLP-1 therapy may be suitable for you